Delivery Order SPE2DB22D3004-SPE2DB23FQA99
Award Date 5/5/23
Potential Completion Date 5/8/23
Potential Value $8.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation for the supply of XIFAXAN 550 mg tablets. The award, valued at $67,139.49, has a firm fixed price and an ultimate completion date of August 16, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several indefinite delivery contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for delivering a wide...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 mg tablets. The contract, valued at $10,706.57, has a firm fixed price and an ultimate completion date of March 25, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a pharmaceutical distribution company, for the delivery of XIFAXAN 550 MG TABLET 60S. The contract, valued at $12,119.86, is a firm fixed-price delivery order with a completion date of May 19, 2023. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a $6,122.56 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide XIFAXAN 550 mg tablets. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,020.90, is for the delivery of XIFAXAN 550 mg tablets. The award is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of $999,999,999.00 and runs through November 2026. This IDC serves as the primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The $15,627.85 firm fixed-price delivery order has a completion date of June 11, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, is the prime contractor and holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,996.61 firm fixed-price contract is for the delivery of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product, with a period of performance ending on January 2, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 MG TABLET 60S, a pharmaceutical product. The $19,179.94 firm fixed-price delivery order has an ultimate completion date of December 31, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle for providing a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp for the supply of XIFAXAN 550 mg tablets. The contract has a ceiling value of $9,118.61 and a completion date of August 23, 2024. AmerisourceBergen, a major pharmaceutical distributor in the United States, has been awarded this firm fixed-price contract to provide the specified medication to support federal healthcare programs and military treatment facilities. The...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of XIFAXAN 550 mg tablets. The $56,660.39 contract has a performance period ending on May 27, 2022 and is a firm fixed-price arrangement. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...